SCHEMBL4197117

SCHEMBL4197117

N=CCCCCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29280653 0.97 DNM1 (0.50)
SCHEMBL5842344 0.97
SCHEMBL9309574 0.97 DNM1 (0.50)
SCHEMBL4201088 0.90
Hydrochloric Acid SCHEMBL29170713 0.78
SCHEMBL250773 0.78
SCHEMBL4199296 0.74
SCHEMBL22485676 0.73
SCHEMBL7517212 0.73
SCHEMBL106292 0.72 NFKB1 (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4223875-A1 SIRNA OF ANGIOPOIETIN-LIKE 3 (ANGPTL3) AND USE THEREOF Nanopeptide (Qingdao) Biotechnology Ltd. (CN) 2023-08-09 EP disclosed
US-20220151731-A1 LASER APPARATUS AND METHOD OF USE FOR DENTAL SURGERY MILLENNIUM HEALTHCARE TECH INC (US) 2022-05-19 US disclosed
WO-2014110705-A9 HETEROCYCLE-SUBSTITUTED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME CORP. (US) 2015-03-05 WO disclosed
WO-2014110705-A1 HETEROCYCLE-SUBSTITUED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME CORP. (US) 2014-07-24 WO disclosed
CN-102448920-A Antiviral compounds and uses thereof ABBOTT LAB 2012-05-09 CN disclosed
US-20090012054-A1 Cephem Compounds and Use as Antimicrobial Agents ASTELLAS PHARMA INC. (JP) 2009-01-08 US disclosed
EP-1994035-A1 CEPHEM COMPOUNDS AND USE AS ANTIMICROBIAL AGENTS Astellas Pharma Inc. (JP) 2008-11-26 EP disclosed
WO-2007119511-A1 CEPHEM COMPOUNDS AND USE AS ANTIMICROBIAL AGENTS ASTELLAS PHARMA INC. (JP) 2007-10-25 WO disclosed